WEREWOLF THERAPEUTICS INC. - COMMON STOCK
1.2250
13-March-25 12:17:05
15 minutes delayed
Stocks
-0.0050
-0.41%
Today's range
1.2010 - 1.2600
ISIN
N/A
Source
NASDAQ
-
Werewolf Therapeutics Appoints Meeta Chatterjee, Ph.D., to its Board of Directors
28 Oct 2021 16:01:00 By Nasdaq GlobeNewswire
-
27 Oct 2021 07:30:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Upcoming Next-Gen Cytokine Therapeutics Summit
14 Sep 2021 08:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at H. C. Wainwright Global Investment Conference
08 Sep 2021 08:00:03 By Nasdaq GlobeNewswire
-
18 Aug 2021 07:30:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update
12 Aug 2021 07:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Announces Its Addition to the Russell 2000® Index
24 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Chulani Karunatilake, Ph.D. as Chief Technology Officer
15 Jun 2021 07:00:01 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Reports First Quarter 2021 Financial Results
10 Jun 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics Appoints Mike Sherman to its Board of Directors
28 May 2021 07:00:00 By Nasdaq GlobeNewswire
-
Werewolf Therapeutics to Present at Jefferies Virtual Healthcare Conference 2021
27 May 2021 07:30:00 By Nasdaq GlobeNewswire